Method for detecting human microsatellite instability site, and use thereof
OwnerXin HUANG, Ying JIANGinventors
Life of this patent
Estimating the term…
Abstract
A method for detecting a human microsatellite instability (MSI) site involves a primer, a probe, and a detection system used for detecting an MSI. The present method and kit thereof may be used for detecting whether MSI-H is present in a tumor patient, and provide medication guidance or provide risk assessment guidance according to a detection result.
Claims17
Use of a human Microsatellite Instability (MSI) site detection reagent in the preparation of a diagnostic reagent or kit for the diagnosis of MSI-related diseases and/or for the prognosis of MSI-related diseases;
- wherein the MSI site is selected from one or more sites in the following group A:
- (Z1) chr3:30650236-30650508;
- (Z2) chr11:106739898-106740117;
- (Z3) chr16:18841298-18841518;
- (Z4) chr17:19411505-19411722;
- (Z5) chr20:62921533-62921750;
- (Z6) chr2:47408320-47408461;
- (Z7) chr2:147906719-147906938;
- (Z8) chr6:142407071-142407290;
- (Z9) chr14:93268657-93268877;
- (Z10) chr20:47779916-47780134;
- (Z11) chr7:143306180-143306440;
- (Z12) chr1:201819424-201819543;
- (Z13) chr1:201771449-201771558;
- (Z14) chr2:61827581-61827677;
- (Z15) chr2:147857500-147857584;
- (Z16) chr4:82821524-82821646;
- (Z17) chr5:172998578-172998712;
- (Z18) chr6:142337918-142338138;
- (Z19) chr14:93244766-93244900;
- (Z20) chr15:45593287-45593508;
- (Z21) chr15:33349068-33349160;
- (Z22) chr15:33764931-33765150;
- (Z23) chr16:18854033-18854164.
A reagent for the detection of human Microsatellite Instability (MSI) sites, wherein the sites is selected from sites 1-10 in chromosome hg38 (SEQ ID NO.:
- 1-10);
- wherein the reagent is selected from the following group:
- (a) The first primer pair for detecting MSI at chr3 site 1 (SEQ ID NO.:1), where the first primer pair comprises primers shown in SEQ ID NO.:11 and 12;
- (b) The second primer pair for detecting MSI at chr11 site 2 (SEQ ID NO.:2), in which the second primer pair comprises primers shown in SEQ ID NO.:19 and 20;
- (c) The third primer pair for detecting MSI at chr16 site 3 (SEQ ID NO.:3), in which the third primer pair comprises primers shown in SEQ ID NO.:23 and 24;
- (d) The fourth primer pair for detecting MSI at chr17 site 4 (SEQ ID NO.:4), where the fourth primer pair comprises the primers shown in SEQ ID NO.:25 and 26;
- (e) The fifth primer pair for detecting MSI at chr20 site 5 (SEQ ID NO.:5), where the fifth primer pair comprises primers shown in SEQ ID NO.:29 and 30;
- (f) The sixth primer pair for detecting MSI at chr2 site 6 (SEQ ID NO.:6), where the sixth primer pair comprises primers shown in SEQ ID NO.:13 and 14;
- (g) The seventh primer pair for detecting MSI at chr2 site 7 (SEQ ID NO.:7), where the seventh primer pair comprises primers shown in SEQ ID NO.:15 and 16;
- (h) The eighth primer pair for detecting MSI at chr6 site 8 (SEQ ID NO.:8), where the eighth primer pair comprises the primers shown in SEQ ID NO.:17 and 18;
- (i) The ninth primer pair for detecting MSI at chr14 site 9 (SEQ ID NO.:9), where the fourth primer pair comprises the primers shown in SEQ ID NO.:21 and 22;
- (j) The tenth primer pair for detecting MSI at chr20 site 10 (SEQ ID NO.:10), where the tenth primer pair comprises primers shown in SEQ ID NO.:27 and 28;
- any combinations of (a) to (j) above.
A combination of detection reagents, and the combination of detection reagents comprising n detection reagents for detecting human microsatellite instability (MSI) sites, wherein the MSI site is selected from the site of group A, and n is a positive integer of ≥2;
- preferably, n is 2-25, and more preferably, n is 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, or 23.
A method for detecting MSI in the sample to be tested, comprising steps:
- (S1) A PCR reaction system is provided, the PCR reaction system comprises samples to be tested as templates and primer pairs for amplification;
- and the primer pairs are selected from the following group:
- (a) The first primer pair for detecting MSI at chr3 site 1 (SEQ ID NO.:1), where the first primer pair comprises primers shown in SEQ ID NO.:11 and 12;
- (b) The second primer pair for detecting MSI at chr11 site 2 (SEQ ID NO.:2), in which the second primer pair comprises primers shown in SEQ ID NO.:19 and 20;
- (c) The third primer pair for detecting MSI at chr16 site 3 (SEQ ID NO.:3), in which the third primer pair comprises primers shown in SEQ ID NO.:23 and 24;
- (d) The fourth primer pair for detecting MSI at chr17 site 4 (SEQ ID NO.:4), where the fourth primer pair comprises the primers shown in SEQ ID NO.:25 and 26;
- (e) The fifth primer pair for detecting MSI at chr20 site 5 (SEQ ID NO.:5), where the fifth primer pair comprises primers shown in SEQ ID NO.:29 and 30;
- (f) The sixth primer pair for detecting MSI at chr2 site 6 (SEQ ID NO.:6), where the sixth primer pair comprises primers shown in SEQ ID NO.:13 and 14;
- (g) The seventh primer pair for detecting MSI at chr2 site 7 (SEQ ID NO.:7), where the seventh primer pair comprises primers shown in SEQ ID NO.:15 and 16;
- (h) The eighth primer pair for detecting MSI at chr6 site 8 (SEQ ID NO.:8), where the eighth primer pair comprises the primers shown in SEQ ID NO.:17 and 18;
- (i) The ninth primer pair for detecting MSI at chr14 site 9 (SEQ ID NO.:9), where the fourth primer pair comprises the primers shown in SEQ ID NO.:21 and 22;
- (j) The tenth primer pair for detecting MSI at chr20 site 10 (SEQ ID NO.:10), where the tenth primer pair comprises primers shown in SEQ ID NO.:27 and 28;
- any combinations of (a) to (j) above;
- (S2) the PCR reaction system of step (51) is subjected to PCR reaction to obtain an amplification product;
- (S3) The amplification product generated in step (S2) is analyzed to obtain the MSI of the sample to be tested;
- wherein taking the total number of detected sites P=5 as an example, If the number of MSI sites in the sample PMSI≥2, it is judged to be highly unstable (MSI-H);
- If the number of MSI sites in the sample PMSI=1, it is judged to be lowly unstable (MSI-L);
- If the number of MSI sites in the sample PMSI=0, it is judged to be stable (MSS).
Dependencies are inferred from the claim text.